Souche, C.; Fouillet, J.; Rubira, L.; Donzé, C.; Deshayes, E.; Fersing, C.
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. Int. J. Mol. Sci. 2024, 25, 462.
https://doi.org/10.3390/ijms25010462
AMA Style
Souche C, Fouillet J, Rubira L, Donzé C, Deshayes E, Fersing C.
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. International Journal of Molecular Sciences. 2024; 25(1):462.
https://doi.org/10.3390/ijms25010462
Chicago/Turabian Style
Souche, Céleste, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Emmanuel Deshayes, and Cyril Fersing.
2024. "Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy" International Journal of Molecular Sciences 25, no. 1: 462.
https://doi.org/10.3390/ijms25010462
APA Style
Souche, C., Fouillet, J., Rubira, L., Donzé, C., Deshayes, E., & Fersing, C.
(2024). Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. International Journal of Molecular Sciences, 25(1), 462.
https://doi.org/10.3390/ijms25010462
